Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications
Clinical trial NCT00993915 · COMPLETED
Trial details
- NCT number
- NCT00993915
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-04-01
- Primary completion
- 2011-12-01
- Enrollment
- 687
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.